The Eisai company has got approval by the Ministry of Health of the Russian Federation on the use of antiepileptic drug Fycompa® in children
.
Main Author: | article Editorial |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-02-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Online Access: | https://www.epilepsia.su/jour/article/view/627 |
Similar Items
-
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
by: O. A. Pylaeva, et al.
Published: (2015-04-01) -
SERVICE-ORIENTED ANALYSIS AND DESIGN FOR EISAI MANAGEMENT PROCESS IMPROVEMENT
by: Ying-Wei Chen, et al.
Published: (2011) -
LIST OF DOCUMENTS PUBLISHED BY GOVERNMENT OF RUSSIAN FEDERATION AND DEPARTMENT OF STATE SANITARY SURVEILLANCE OF MINISTRY OF PUBLIC HEALTH OF RUSSIAN FEDERATION ON SEVERE ACUTE RESPIRATORY SYNDROME
by: article Editorial
Published: (2020-04-01) -
ORDER № 621 AS OF NOVEMBER 5, 2008 ON THE AMENDMENTS TO THE ORDER OF THE MINISTRY OF PUBLIC HEALTH AND SOCIAL DEVELOPMENT OF THE RUSSIAN FEDERATION NO. 283 AS OF NOVEMBER 26, 2004 ON THE CHIEF EXTERNAL EXPERTS OF THE MINISTRY OF PUBLIC HEALTH AND SOCIAL DEVELOPMENT OF THE RUSSIAN FEDERATION
by: article editorial
Published: (2008-11-01) -
ORDER № 621 AS OF NOVEMBER 5, 2008 ON THE AMENDMENTS TO THE ORDER OF THE MINISTRY OF PUBLIC HEALTH AND SOCIAL DEVELOPMENT OF THE RUSSIAN FEDERATION NO. 283 AS OF NOVEMBER 26, 2004 ON THE CHIEF EXTERNAL EXPERTS OF THE MINISTRY OF PUBLIC HEALTH AND SOCIAL DEVELOPMENT OF THE RUSSIAN FEDERATION
by: article editorial
Published: (2008-11-01)